Single patient cancer treatment study
Part of Cancer clinical trials.
This study creates a unique treatment plan based on the genetic changes found in your tumor. A team of experts will review your cancer's molecular profile to decide the best next therapy for you, even if standard options are not clear.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had genomic testing done on your tumor to look for genetic changes.
- Your doctor and a hospital expert team review your results to decide on a personalized treatment.
- You are willing to try a treatment that is made specifically for your cancer's genetic makeup.
- There may not be standard treatment options available for your type of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial sets up a “molecular tumor board,” a team that reviews your tumor’s lab results and helps your doctor choose treatment options. It may help by making sense of tumor test findings so decisions are more personalized.
This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.
This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.
This trial tests whether using a personalized approach (matching your tumor's genetic profile to a targeted drug) can help people with advanced solid cancers live longer. It is for people whose cancer is not responding to standard treatments and who have a genetic change that can be targeted by an FDA-approved drug not usually used for their cancer type.
This trial looks at a more tailored way to choose treatment for people with rare cancers that have spread or grown locally and can’t be cured with standard therapies. The goal is to better target the tumor to improve the chance of tumor shrinkage or eradication.
This trial tests whether tailoring treatment to your tumor's specific genetic makeup can help when standard treatments are no longer working. It may give you access to therapies that are more likely to work for your cancer.
Hear when a new Advanced Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.